Pseudobulbar Affect (PBA) - Medicaid

Prior Authorization, Quantity Limit

Pseudobulbar Affect (PBA) - Commercial

Prior Authorization, Quantity Limit

Kerendia - Medicaid

Prior Authorization, Quantity Limit

Kerendia - Commercial

Step Therapy, Quantity Limit

Interstitial Lung Disease - Commercial

Prior Authorization, Quantity Limit

Interleukin-5 (IL-5) Inhibitors - Medicaid

Prior Authorization, Quantity Limit

Interleukin-5 (IL-5) Inhibitors - Commercial

Prior Authorization, Quantity Limit

Interleukin-4 (IL-4) Inhibitors - Medicaid

Prior Authorization, Quantity Limit

P36-23 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama

P37-23 New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective July 31, 2023